Turing Pharmaceuticals AG — Form D/A
Turing Pharmaceuticals AG of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2015-08-19. $90.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-08-19
- Form: D/A
- Accession: 0001650139-15-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $90.3M
- Minimum investment: $25K
- Investors: 43
- Date of first sale: 2015-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245166
Issuer
- Name: Turing Pharmaceuticals AG
- CIK: 0001650139
- Entity type: Corporation
- Jurisdiction: SWITZERLAND
- Incorporated: 2014
- Address: 1177 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
- Phone: (646) 356-5560
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Walter Blum | Director | Baar, V8 |
| Alan Geller | Director | New York, NY |
| MARTIN SHKRELI | Director | NEW YORK, NY |
| Ron Tilles | Director | Parsippany, NJ |
| Michael Harrison | Executive Officer | New York, NY |
| MARTIN SHKRELI | Executive Officer | NEW YORK, NY |
| Howard Dorfman | Executive Officer | New York, NY |
Other filings by this issuer (1)
More